Clinical trial
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
NCT05206448 is registered in ClinicalTrials.gov with Rachel Mejia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
- Lead sponsor
- Rachel Mejia
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- October 26, 2020
- Completion date
- December 31, 2025
- Enrollment
- 190 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.